Table 1.
Pathogenic Type | Specific Disease Entity | Pattern of Injury: Focal or Diffuse | Scores or Class |
---|---|---|---|
Immune-complex GNa | IgA nephropathy, IgA vasculitis, lupus nephritis, infection-related GN, fibrillary GN with polyclonal Ig deposits | Mesangial, endocapillary, exudative, membranoproliferative, necrotizing, crescentic, sclerosing, or multipleb | Oxford/MEST scores for IgA nephropathy |
ISN/RPS class for lupus nephritis | |||
Pauci-immune GN | MPO-ANCA GN, proteinase 3-ANCA GN, ANCA-negative GN | Necrotizing, crescentic, sclerosing, or multipleb | Focal, crescentic, mixed, or sclerosing class (Berden/EUVAS class) |
Anti-GBM GN | Anti-GBM GN | Necrotizing, crescentic, sclerosing, or mixedb | |
Monoclonal Ig GNa | Monoclonal Ig deposition disease, proliferative GN with monoclonal Ig deposits, immunotactoid glomerulopathy, fibrillary GN with monoclonal Ig deposits | Mesangial, endocapillary, exudative, membranoproliferative, necrotizing, crescentic, sclerosing, or multipleb | |
C3 glomerulopathy | C3 GN, dense deposit disease | Mesangial, endocapillary, exudative, membranoproliferative, necrotizing, crescentic, sclerosing, or multipleb |
MEST, mesangial hypercellularity, endocapillary hypercellularity, segmental sclerosis, interstitial fibrosis/tubular atrophy; ISN/RPS, International Society of Nephrology/Renal Pathology Society; EUVAS, European vasculitis study group.
Some pathologists use the terms immune complex–mediated GN, monoclonal Ig–associated GN, etc. It is up to the discretion of the pathologist to use these terms.
Multiple patterns include two or more patterns of injury. The patterns should be stated (e.g., focal mesangial proliferative, crescentic, and sclerosing or diffuse necrotizing, crescentic, and sclerosing).